CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys...
Phase 3
Nashville, Tennessee, United States and 66 other locations
Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:* E...
Phase 3
Nashville, Tennessee, United States and 29 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Nashville, Tennessee, United States and 338 other locations
Researchers are looking for a better way to treat people who have chronic kidney disease (CKD), CKD is a condition in which the kidneys...
Phase 2
Nashville, Tennessee, United States and 168 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Nashville, Tennessee, United States and 642 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Nashville, Tennessee, United States and 305 other locations
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with ...
Nashville, Tennessee, United States and 5 other locations
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
Phase 1, Phase 2
Nashville, Tennessee, United States and 7 other locations
savolitinib, is effective in treating patients with MET-driven PRCC, how it compares with another medication frequently used to treat this disease...
Phase 3
Nashville, Tennessee, United States and 58 other locations
The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in...
Nashville, Tennessee, United States and 98 other locations
Clinical trials
Research sites
Resources
Legal